Physicians' perspectives on the treatment of osteoporosis patients with bisphosphonates
Tao Gu,1 Debra F Eisenberg Lawrence,1 Judith J Stephenson,1 Jingbo Yu2 1HealthCore, Wilmington, DE, 2Merck & Co., Inc., Kenilworth, NJ, USA Background: Noncompliance with bisphosphonate therapy among osteoporosis patients attenuates the reduction of fracture risk. The objective of this stu...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/309fb60186fe45d7a56b54deb089379a |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:309fb60186fe45d7a56b54deb089379a |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:309fb60186fe45d7a56b54deb089379a2021-12-02T06:05:30ZPhysicians' perspectives on the treatment of osteoporosis patients with bisphosphonates1178-1998https://doaj.org/article/309fb60186fe45d7a56b54deb089379a2016-02-01T00:00:00Zhttps://www.dovepress.com/physiciansrsquo-perspectives-on-the-treatment-of-osteoporosis-patients-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Tao Gu,1 Debra F Eisenberg Lawrence,1 Judith J Stephenson,1 Jingbo Yu2 1HealthCore, Wilmington, DE, 2Merck & Co., Inc., Kenilworth, NJ, USA Background: Noncompliance with bisphosphonate therapy among osteoporosis patients attenuates the reduction of fracture risk. The objective of this study was to assess physicians’ prescribing considerations, preferences for osteoporosis treatments, and perceptions of patients’ compliance with oral bisphosphonates. Methods: This was an online survey of US physicians identified in the HealthCore Integrated Research Database (HIRDSM) as prescribing oral bisphosphonates to women aged ≥55 years. The survey gauged physicians’ prescribing considerations and preferences for various types of osteoporosis medications. The physicians were asked to predict patient persistence and compliance, and rate various reasons for noncompliance. Results: Bone mineral density, long-term medication use (eg, corticosteroids), and a history of fracture were ranked as major considerations by 94.9%, 88.6%, and 86.7% of participating physicians (N=158), respectively, when deciding whether to treat an osteoporosis patient. Most physicians expressed a preference for prescribing weekly or monthly oral bisphosphonates, for both newly diagnosed patients (54.4% and 34.2%, respectively) and long-term users of oral bisphosphonates (40.5% and 36.1%, respectively). Most physicians (23.4% always, 58.9% sometimes) incorporated a drug holiday into their prescribing patterns. Although most physicians predicted that more than half of the patients would comply with the prescribed medication for at least a year, 17.7% predicted that less than half of the patients would be compliant in the 1st year, and 29.7% predicted the same result for compliance beyond 1 year. In the opinion of the majority of physicians, the major reasons for noncompliance with oral bisphosphonates were intolerance of a medication due to a gastrointestinal condition (71.5%) and medication side effects (69.6%). Conclusion: US physicians consider several relevant risk factors when deciding whether to prescribe pharmacotherapy and exhibit a preference for weekly or monthly regimens. The physicians estimated a substantial minority of the patients to be noncompliant with oral bisphosphonates, for reasons including primarily gastrointestinal intolerance and medication-related side effects. Keywords: osteoporosis, bisphosphonates, physician’s practice patterns, cross-sectional studies, patient compliance Gu TEisenberg Lawrence DFStephenson JJYu JDove Medical PressarticleOsteoporosisdiphosphonatesphysician's practice patternscross-sectional studiespatient complianceGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 11, Pp 1-8 (2016) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Osteoporosis diphosphonates physician's practice patterns cross-sectional studies patient compliance Geriatrics RC952-954.6 |
| spellingShingle |
Osteoporosis diphosphonates physician's practice patterns cross-sectional studies patient compliance Geriatrics RC952-954.6 Gu T Eisenberg Lawrence DF Stephenson JJ Yu J Physicians' perspectives on the treatment of osteoporosis patients with bisphosphonates |
| description |
Tao Gu,1 Debra F Eisenberg Lawrence,1 Judith J Stephenson,1 Jingbo Yu2 1HealthCore, Wilmington, DE, 2Merck & Co., Inc., Kenilworth, NJ, USA Background: Noncompliance with bisphosphonate therapy among osteoporosis patients attenuates the reduction of fracture risk. The objective of this study was to assess physicians’ prescribing considerations, preferences for osteoporosis treatments, and perceptions of patients’ compliance with oral bisphosphonates. Methods: This was an online survey of US physicians identified in the HealthCore Integrated Research Database (HIRDSM) as prescribing oral bisphosphonates to women aged ≥55 years. The survey gauged physicians’ prescribing considerations and preferences for various types of osteoporosis medications. The physicians were asked to predict patient persistence and compliance, and rate various reasons for noncompliance. Results: Bone mineral density, long-term medication use (eg, corticosteroids), and a history of fracture were ranked as major considerations by 94.9%, 88.6%, and 86.7% of participating physicians (N=158), respectively, when deciding whether to treat an osteoporosis patient. Most physicians expressed a preference for prescribing weekly or monthly oral bisphosphonates, for both newly diagnosed patients (54.4% and 34.2%, respectively) and long-term users of oral bisphosphonates (40.5% and 36.1%, respectively). Most physicians (23.4% always, 58.9% sometimes) incorporated a drug holiday into their prescribing patterns. Although most physicians predicted that more than half of the patients would comply with the prescribed medication for at least a year, 17.7% predicted that less than half of the patients would be compliant in the 1st year, and 29.7% predicted the same result for compliance beyond 1 year. In the opinion of the majority of physicians, the major reasons for noncompliance with oral bisphosphonates were intolerance of a medication due to a gastrointestinal condition (71.5%) and medication side effects (69.6%). Conclusion: US physicians consider several relevant risk factors when deciding whether to prescribe pharmacotherapy and exhibit a preference for weekly or monthly regimens. The physicians estimated a substantial minority of the patients to be noncompliant with oral bisphosphonates, for reasons including primarily gastrointestinal intolerance and medication-related side effects. Keywords: osteoporosis, bisphosphonates, physician’s practice patterns, cross-sectional studies, patient compliance |
| format |
article |
| author |
Gu T Eisenberg Lawrence DF Stephenson JJ Yu J |
| author_facet |
Gu T Eisenberg Lawrence DF Stephenson JJ Yu J |
| author_sort |
Gu T |
| title |
Physicians' perspectives on the treatment of osteoporosis patients with bisphosphonates |
| title_short |
Physicians' perspectives on the treatment of osteoporosis patients with bisphosphonates |
| title_full |
Physicians' perspectives on the treatment of osteoporosis patients with bisphosphonates |
| title_fullStr |
Physicians' perspectives on the treatment of osteoporosis patients with bisphosphonates |
| title_full_unstemmed |
Physicians' perspectives on the treatment of osteoporosis patients with bisphosphonates |
| title_sort |
physicians' perspectives on the treatment of osteoporosis patients with bisphosphonates |
| publisher |
Dove Medical Press |
| publishDate |
2016 |
| url |
https://doaj.org/article/309fb60186fe45d7a56b54deb089379a |
| work_keys_str_mv |
AT gut physicians39perspectivesonthetreatmentofosteoporosispatientswithbisphosphonates AT eisenberglawrencedf physicians39perspectivesonthetreatmentofosteoporosispatientswithbisphosphonates AT stephensonjj physicians39perspectivesonthetreatmentofosteoporosispatientswithbisphosphonates AT yuj physicians39perspectivesonthetreatmentofosteoporosispatientswithbisphosphonates |
| _version_ |
1718400043710414848 |